Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen

被引：0
作者：
Annlia Paganini-Hill
Linda J. Clark
机构：
[1] Keck School of Medicine of the University of Southern California,Department of Preventive Medicine
来源：
Breast Cancer Research and Treatment | 2000年 / 64卷
关键词：
cognitive function; memory; tamoxifen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background. Tamoxifen is an anti-estrogen used in the treatment of breast cancer and to reduce the incidence of breast cancer in high risk women. Although the brain is an estrogen target organ and several studies have found a beneficial effect of estrogen on cognitive function, the effect of tamoxifen on cognition has not been reported. Therefore, we initiated a follow-up study of women who had participated in a study of breast cancer to assess the effect of tamoxifen treatment on cognitive function.
引用
收藏
页码：165 / 176
页数：11
相关论文
共 50 条
[41]   Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy [J].
Honma, Naoko ;
Horii, Rie ;
Iwase, Takuji ;
Saji, Shigehira ;
Younes, Mamoun ;
Ito, Yoshinori ;
Akiyama, Futoshi .
BREAST CANCER, 2013, 20 (04) :323-330
[42]   Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen [J].
Kok, Marleen ;
Linn, Sabine C. ;
Van Laar, Ryan K. ;
Jansen, Maurice P. H. M. ;
van den Berg, Teun M. ;
Delahaye, Leonie J. M. J. ;
Glas, Annuska M. ;
Peterse, Johannes L. ;
Hauptmann, Michael ;
Foekens, John A. ;
Klijn, Jan G. M. ;
Wessels, Lodewyk F. A. ;
Van't Veer, Laura J. ;
Berns, Els M. J. J. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (02) :275-283
[43]   Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis [J].
P. Hadji ;
V. Ziller ;
J. Kyvernitakis ;
M. Bauer ;
G. Haas ;
N. Schmidt ;
K. Kostev .
Breast Cancer Research and Treatment, 2013, 138 :185-191
[44]   Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors [J].
Breckenridge, Lynn M. ;
Bruns, Gina L. ;
Todd, Briana L. ;
Feuerstein, Michael .
PSYCHO-ONCOLOGY, 2012, 21 (01) :43-53
[45]   Different coexisting gynecological and endometrial pathologies in postmenopausal breast cancer patients treated with tamoxifen [J].
Cohen, I ;
Beyth, Y ;
Bernheim, J ;
Shapira, J ;
Cordoba, M ;
Aviram, R ;
Figer, A ;
Yigael, D ;
Altaras, MM .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 46 (02) :123-129
[46]   Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis [J].
Hadji, P. ;
Ziller, V. ;
Kyvernitakis, J. ;
Bauer, M. ;
Haas, G. ;
Schmidt, N. ;
Kostev, K. .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (01) :185-191
[47]   Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [J].
João Paulo Bianchi Ximenez ;
Jurandyr Moreira de Andrade ;
Maria Paula Marques ;
Eduardo Barbosa Coelho ;
Guilherme Suarez-Kurtz ;
Vera Lucia Lanchote .
BMC Pharmacology and Toxicology, 20
[48]   Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [J].
Ximenez, Joao Paulo Bianchi ;
de Andrade, Jurandyr Moreira ;
Marques, Maria Paula ;
Coelho, Eduardo Barbosa ;
Suarez-Kurtz, Guilherme ;
Lanchote, Vera Lucia .
BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (Suppl 1)
[49]   Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial [J].
Phillips, Kelly-Anne ;
Aldridge, Julie ;
Ribi, Karin ;
Sun, Zhuoxin ;
Thompson, Alastair ;
Harvey, Vernon ;
Thuerlimann, Beat ;
Cardoso, Fatima ;
Pagani, Olivia ;
Coates, Alan S. ;
Goldhirsch, Aron ;
Price, Karen N. ;
Gelber, Richard D. ;
Bernhard, Juerg .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) :221-226
[50]   Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial [J].
Kelly-Anne Phillips ;
Julie Aldridge ;
Karin Ribi ;
Zhuoxin Sun ;
Alastair Thompson ;
Vernon Harvey ;
Beat Thürlimann ;
Fatima Cardoso ;
Olivia Pagani ;
Alan S. Coates ;
Aron Goldhirsch ;
Karen N. Price ;
Richard D. Gelber ;
Jürg Bernhard .
Breast Cancer Research and Treatment, 2011, 126 :221-226
12345